The American Society Of Gene & Cell Therapy
- Assets
- $11.5m
- Revenue
- $6.5m
- Investments
- $0.0
- Employees
- 30
- Location
- Waukesha, WI
- Founding
- 04/1997
- Data as of
- 12/2020
- EIN
- 91-1766321
Organization Overview
The American Society Of Gene & Cell Therapy is located in Waukesha, WI. The organization was established in 1997. According to its NTEE Classification (H20) the organization is classified as: Birth Defects & Genetic Diseases Research, under the broad grouping of Medical Research and related organizations. As of 12/2021, American Society Of Gene & Cell Therapy employed 30 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. American Society Of Gene & Cell Therapy is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2020, American Society Of Gene & Cell Therapy generated $6.5m in total revenue. This organization has experienced exceptional growth, as over the past 6 years, it has increased revenue by an average of 19.7% each year . All expenses for the organization totaled $4.5m during the year ending 12/2020. While expenses have increased by 15.9% per year over the past 6 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2018, American Society Of Gene & Cell Therapy has awarded 35 individual grants totaling $1,957,500. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2020
Describe the Organization's Mission:
Part 3 - Line 1
ASGCT'S MISSION IS TO ADVANCE KNOWLEDGE, AWARENESS, AND EDUCATION LEADING TO THE DISCOVERY AND CLINICAL APPLICATION OF GENETIC AND CELLULAR THERAPIES TO ALLEVIATE HUMAN DISEASE.
Describe the Organization's Program Activity:
Part 3 - Line 4a
ANNUAL MEETING: THIS IS THE PRIMARY VEHICLE FOR CARRYING OUT THE EDUCATIONAL MISSION OF ASGCT. THE ANNUAL MEETING REPRESENTS THE MAJOR EDUCATIONAL INITIATIVE OF THE SOCIETY.
MOLECULAR THERAPY JOURNALS: PUBLISHING SCHOLARLY JOURNALS IS THE SECOND MAJOR VEHICLE FOR CARRYING OUT THE EDUCATIONAL MISSION OF ASGCT. THE JOURNALS ARE THE WAY ASGCT EDUCATES AND UPDATES RESEARCHERS, CLINICIANS, AND STUDENTS ON THE LATEST ADVANCES IN THE DEVELOPMENT OF NOVEL THERAPEUTICS.
ADVOCACY: ADVOCACY IS THE THIRD MAJOR VEHICLE FOR CARRYING OUT THE EDUCATIONAL MISSION OF ASGCT. THE DEFINING VALUE OF ADVOCACY IS "GENE AND CELL THERAPY WILL HAVE A FINANCIAL IMPACT ON PATIENTS, PROVIDERS, AND PAYERS. ASGCT IS COMMITTED TO UNDERSTANDING THAT IMPACT AND EDUCATING DECISION-MAKERS ENGAGED IN DEVELOPING POLICIES THAT INFLUENCE PATIENT ACCESS TO TREATMENTS."
OTHER PROGRAMS INCLUDE: WORKSHOPS, INTERNATIONAL ONCOLYTIC VIRUS CONFERENCE, POLICY SUMMIT, CAREER DEVELOPMENT PROGRAM, DIVERSITY AND INCLUSION COMMITTEE, CAREER DEVELOPMENT PROGRAM PATIENT EDUCATION PROGRAM, AND THE NEWSLETTER.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
David Barrett Executive Director | Officer | 40 | $252,688 |
Beverly Davidson PHD President | OfficerTrustee | 5 | $0 |
Jeffrey S Chamberlain PHD Vice President | OfficerTrustee | 5 | $0 |
Paloma H Giangrande PHD Treasurer | OfficerTrustee | 5 | $0 |
Stephen J Russell MD PHD Past President | OfficerTrustee | 5 | $0 |
Terence R Flotte MD Secretary | OfficerTrustee | 5 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Robert M Frederickson Consulting Inc Editorial Services | 12/30/21 | $183,844 |
Bgr Government Affairs Llc Advocacy | 12/30/21 | $180,750 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $21,126 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $21,126 |
| Total Program Service Revenue | $6,362,242 |
| Investment income | $84,023 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $6,516,210 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $300,000 |
| Grants and other assistance to domestic individuals. | $73,296 |
| Grants and other assistance to Foreign Orgs/Individuals | $14,204 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $195,295 |
| Compensation of current officers, directors, key employees. | $39,059 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $598,854 |
| Pension plan accruals and contributions | $16,948 |
| Other employee benefits | $45,151 |
| Payroll taxes | $64,592 |
| Fees for services: Management | $924,468 |
| Fees for services: Legal | $66,472 |
| Fees for services: Accounting | $47,662 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $347,908 |
| Advertising and promotion | $108,481 |
| Office expenses | $251,237 |
| Information technology | $353,961 |
| Royalties | $0 |
| Occupancy | $119,417 |
| Travel | $642 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $466,809 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $28,541 |
| Insurance | $25,886 |
| All other expenses | $9,049 |
| Total functional expenses | $4,511,431 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $4,147,144 |
| Savings and temporary cash investments | $2,061,495 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $1,218,924 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $129,741 |
| Net Land, buildings, and equipment | $19,219 |
| Investments—publicly traded securities | $3,900,424 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $46,535 |
| Other assets | $23,500 |
| Total assets | $11,546,982 |
| Accounts payable and accrued expenses | $267,107 |
| Grants payable | $0 |
| Deferred revenue | $962,023 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $1,426 |
| Total liabilities | $1,230,556 |
| Net assets without donor restrictions | $10,316,426 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $11,546,982 |
Grants Awarded
Over the last fiscal year, The American Society Of Gene & Cell Therapy has awarded $1,150,000 in support to 11 organizations.
| Grant Recipient | Amount |
|---|---|
INDIANA UNIVERSITY PURPOSE: CAREER DEVELOPMENT | $200,000 |
Boston, MA PURPOSE: D&I UNDERREPRESENTED AWARD | $100,000 |
CLEMSON UNIVERSITY PURPOSE: D&I UNDERREPRESENTED AWARD | $100,000 |
Somerville, MA PURPOSE: CAREER DEVELOPMENT | $100,000 |
Chapel Hill, NC PURPOSE: CAREER DEVELOPMENT | $100,000 |
REGENTS OF THE UNIVERSITY OF MINNESOTA PURPOSE: CAREER DEVELOPMENT | $100,000 |
Grants Recieved
Over the last fiscal year, we have identified 1 grants that The American Society Of Gene & Cell Therapy has recieved totaling $300,000.
| Awarding Organization | Amount |
|---|---|
Cystic Fibrosis Foundation Bethesda, MD PURPOSE: THERAPEUTICS DISCOVERY RESEARCH | $300,000 |
Endowment Analysis
| Beg. Balance | $244,199 |
| Earnings | $66,435 |
| Net Contributions | $410 |
| Ending Balance | $311,044 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
American Society For Transplantation & Cellular Therapy Chicago, IL | $11,425,659 | $5,528,435 |
The American Society Of Gene & Cell Therapy Waukesha, WI | $11,546,982 | $6,516,210 |
Porter Hills Home Health West Grand Rapids, MI | $637,150 | $3,427,551 |
St Croix Therapy Inc Hudson, WI | $2,512,408 | $2,378,126 |
Pamela B Katten Memorial Leukemia Research Foundation Winnetka, IL | $0 | -$4,449 |
International Zebrafish Society Inc Milwaukee, WI | $421,036 | $263,799 |
Kessel Foundation Fairfield, IA | $130,139 | $0 |
Earth Please Foundation Mount Pleasant, IA | $89 | $21,862 |
Loving Luca Foundation Inc Naperville, IL | $2,519 | $9,686 |
Matthews Wish Ypsilanti, MI | $1,364 | $0 |